NCT04902833 - Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions

Pyruvate Kinase DeficiencyPyruvate Kinase Deficiency AnemiaHereditary Hemolytic AnemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmClonal Myeloid NeoplasmMyeloproliferative NeoplasmAcute Myeloid LeukemiaClonal Cytopenia of Undetermined SignificanceOther Clonal Myeloid NeoplasmUnexplained Coombs-negative Non-immune Hemolytic Anemia

Interventions

PROCEDURE

Blood Draw

Blood specimen 2-4 teaspoons

Trial Locations (1)

02115

RECRUITING

Massachusetts General Hospital, Boston